Buscar
Mostrando ítems 1-10 de 554
Controversies in Systemic Lupus Erythematosus: Are We Treating Our Patients Adequately?
(Wolters Kluwer Health, 2022)
Systemic lupus erythematosus (SLE) is characterized by great clinical heterogeneity. The objectives of its management are to make a timely diagnosis and to initiate treatment as promptly as possible so organ damage can be ...
Controversies in Systemic Lupus Erythematosus 2021 Changing the Paradigm in the Management of Lupus Nephritis
(Wolters Kluwer Health, 2022)
Lupus nephritis (LN) affects about a third of patients with systemic lupus erythematosus. Although the use of conventional therapy has significantly improved the prognosis of LN, the response to treatment remains suboptimal, ...
Enfermedad cutánea ampollosa en el lupus eritematoso sistémicoBullous skin disease in systemic lupus erythematosus
(Universidad de Antioquia, Facultad de MedicinaMedellín, Colombia, 2019)
Lupus eritematoso sistémico ampolloso : dramática respuesta a la terapia con dapsonaBullous Systemic Lupus Erythematosus : dramatic response to dapsone
(Asociación Colombiana de ReumatologíaGrupo de Inmunología Celular e InmunogenéticaGrupo de Reumatología Universidad de Antioquia -GRUA-Bogotá, Colombia, 2022)
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 20 Study Group
(SAGE Publications, 2021)
Introduction: After more than 20years of sustained work, the Latin American Group for the Study of Lupus (GLADEL) has made a significant number of contributions to the field of lupus, not only in the differential role that ...
Is there an effective treatment for late-onset systemic lupus erythematosus?
(Future Science Group, 2013)
Over the past 60 years, overall mortality in systemic lupus erythematosus patients has dramatically decreased, but late mortality, which relates to the damage caused by the disease, its treatments and/or evolving comorbidities, ...
The Rise and Rise of Lupus
(SAGE Publications, 2023)
Despite how difficult the early diagnosis of systemic lupus erythematosus (SLE) is, which is mainly due to the heterogeneity and non-specificity of its clinical manifestations, SLE is currently being diagnosed more frequently ...
Evaluación de los valores séricos de prolactina en lupus eritematoso sistémico.
(Universidad del Zulia, 2016)
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL)-Pan American League of Associations of Rheumatology (PANLAR)
(Seguro Social de Salud (EsSalud)PE, 2018)
El Lupus eritematoso sistémico es una enfermedad autoinmune compleja y heterogenea, que representa un desafío significativo en su diagnóstico y tratamiento. El objetivo de este estudio es desarrollar una guía práctica ...
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR)
(BMJ Publishing Group, 2018)
Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease, represents a significant challenge for both diagnosis and treatment. Patients with SLE in Latin America face special problems that should ...